We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Eurofins Technologies

Siemens Healthineers

  Gold Provides customized electronic systems and advanced imaging, diagnostics, therapy, and healthcare IT solutions for th... read more Featured Products: More products

Download Mobile App





Siemens' RAPIDPoint 500e Blood Gas Analyzer Receives US FDA Clearance to Aid in COVID-19 Care

By LabMedica International staff writers
Posted on 01 Apr 2020
Print article
Image: The RAPIDPoint 500e Blood Gas Analyzer (Photo courtesy of Siemens Healthineers)
Image: The RAPIDPoint 500e Blood Gas Analyzer (Photo courtesy of Siemens Healthineers)
Siemens Healthineers’ (Erlangen, Germany) latest critical care testing solution, the RAPIDPoint 500e Blood Gas Analyzer, has received clearance from the US Food and Drug Administration, and is now available in the US, Europe and countries requiring the CE mark. The RAPIDPoint 500e Blood Gas Analyzer belongs to Siemens’ blood gas portfolio which is supporting COVID-19 response efforts, where blood gas testing plays a critical role in managing infected patients.

The RAPIDPoint 500e Blood Gas Analyzer generates blood gas, electrolyte, metabolite, CO-oximetry, and neonatal bilirubin results, which are used to diagnose and monitor critically ill patients in the intensive care unit, operating room, or emergency room. Blood gas testing is often required for ventilator-assisted patients and those undergoing evaluation for respiratory distress, providing insights into a patient’s oxygenation level. Additionally, the RAPIDPoint 500e Blood Gas Analyzer uses Integri-sense Technology, a comprehensive series of automated functional checks that are designed to deliver accurate test results at the point-of-care.

“Point-of-care teams monitoring respiratory conditions in critical care settings need a blood gas testing solution that delivers fast, accurate results and increases workflow efficiencies. A safe operating environment amid growing concerns about cybersecurity threats in healthcare is also important,” said Christoph Pedain, Head of Point of Care Diagnostics, Siemens Healthineers. “The RAPIDPoint 500e Blood Gas Analyzer has become a trusted instrument in Europe’s endeavor to combat COVID-19 and to help address an unprecedented demand for blood gas testing in affected respiratory patients.”

Related Links:
Siemens Healthineers


Print article

Channels

Microbiology

view channel
Image: Stenotrophomonas maltophilia colonies on sheep blood agar. Cultivation 48 hours in an aerobic atmosphere, 37 °C (Photo courtesy of microbiologyinpictures).

Global Spread of the Multi-Resistant Pathogen Stenotrophomonas Maltophilia Revealed

Stenotrophomonas maltophilia strains occur in several natural and human associated ecosystems. The bacterium was long regarded as relatively unproblematic, but is now considered to be one of the most feared... Read more
Copyright © 2000-2020 Globetech Media. All rights reserved.